Management of Drug Overdose Not Responding to Naloxone

Initial Assessment and Management

The American Heart Association recommends maintaining airway and breathing support as the primary intervention, even if oxygen saturation appears adequate, since the clinical presentation of respiratory distress is more important than the oxygen saturation number alone 1
The American College of Emergency Physicians suggests continuing to monitor vital signs closely, as stable vitals can deteriorate in overdose situations 2
The American Heart Association advises considering escalating to bag-mask ventilation if respiratory effort becomes inadequate, as rescue breathing or bag-mask ventilation should be maintained until spontaneous breathing returns 3

Non-response to naloxone may indicate polysubstance overdose involving non-opioid substances, such as benzodiazepines or xylazine, according to the American College of Emergency Physicians 4
The American Heart Association notes that non-response to naloxone may also indicate metabolic insults, such as hypoxia or hypercarbia, or the presence of synthetic opioids requiring higher or repeated doses 3

The American College of Emergency Physicians recommends being aware that xylazine, an α-2 agonist veterinary sedative, is increasingly found in the opioid supply and is not reversed by naloxone 5
In cases of suspected xylazine-opioid co-intoxication, the American College of Emergency Physicians suggests focusing treatment on the opioid component while providing supportive care 4

The American Heart Association advises considering endotracheal intubation for definitive airway management if respiratory status continues to deteriorate despite naloxone administration and supportive measures 6
The American College of Emergency Physicians recommends continuing standard BLS/ALS care if return of spontaneous breathing does not occur 7

The American College of Emergency Physicians suggests observing all patients for at least 2 hours after naloxone administration, with longer observation periods for patients suspected of taking long-acting opioids 1
The American Heart Association notes that patients who respond to naloxone may develop recurrent CNS or respiratory depression as naloxone's duration of action is shorter than many opioids 8

The American College of Emergency Physicians warns against focusing solely on opioid reversal when polysubstance overdose may be present 4
The American Heart Association advises against administering excessive naloxone doses in an attempt to achieve full consciousness rather than adequate ventilation 4
The American College of Emergency Physicians recommends recognizing that stable vital signs and good oxygenation can deteriorate rapidly in overdose situations 2
The American Heart Association suggests not delaying definitive airway management when naloxone is ineffective 6